Free Trial

Cidara Therapeutics (CDTX) SEC Filings & 10K Form

Cidara Therapeutics logo
$13.09
+0.09 (+0.69%)
(As of 11/1/2024 ET)

Recent Cidara Therapeutics SEC Filings

DateFilerForm TypeView
10/02/2024
4:19 PM
Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:25 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:27 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:30 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
7:10 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
5:26 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:27 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:18 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:35 PM
Cidara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/13/2024
3:19 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:15 PM
Cidara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
11:15 PM
Cidara Therapeutics (Filer)
Form EFFECT
07/31/2024
4:25 PM
Cidara Therapeutics (Filer)
Form 424B3
07/29/2024
3:45 PM
BCLS Fund III Investments, LP (Filed by)
Cidara Therapeutics (Subject)
Form SC 13G
07/29/2024
3:31 PM
Canaan XII L.P. (Filed by)
Cidara Therapeutics (Subject)
Form SC 13G
07/22/2024
4:09 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4/A
07/22/2024
4:11 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:54 PM
Canale-Theakston Carin (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:54 PM
Cidara Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/19/2024
3:55 PM
Bassler Bonnie L (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:56 PM
BURGESS DANIEL D (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:16 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:49 PM
Cidara Therapeutics (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:52 PM
Cidara Therapeutics (Issuer)
Mineo Chrysa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:53 PM
Cidara Therapeutics (Issuer)
Merson James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:38 PM
Cidara Therapeutics (Issuer)
Tadvalkar Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:40 PM
Cidara Therapeutics (Issuer)
Spencer Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:31 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:26 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:36 PM
Cidara Therapeutics (Filer)
Form DEF 14A
06/03/2024
3:38 PM
Cidara Therapeutics (Filer)
Form DEFA14A
05/23/2024
3:59 PM
Cidara Therapeutics (Filer)
Form PRE 14A
05/15/2024
3:22 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
7:00 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
3:34 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2024
3:37 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:07 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:09 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
4:18 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
7:02 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
7:00 AM
Cidara Therapeutics (Filer)
Form NT 10-K
Market "Famine" Coming (Ad)

Market Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicted the 2020 crash a month before it happened...

For a limited time, he's revealing his latest forecast here.
03/20/2024
5:46 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:47 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:47 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:48 PM
Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:48 PM
Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:45 PM
Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:46 PM
Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:47 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:48 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:48 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:22 PM
Cidara Therapeutics (Filer)
Form DEF 14A
02/14/2024
9:18 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cidara Therapeutics (Subject)
Form SC 13G/A
02/09/2024
7:00 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
6:33 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
12:22 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CDTX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners